Table 4. Results of Cox Proportional Hazards Regression for Survival by Histologic Subtype.

	Progression-Free Survival	P value	Disease-Specific Survival	P value
Non-serous papillary
No hyperlipidemia	1		1
Hyperlipidemia not using statins	0.85 (0.11–6.45)	0.88	1.45 (0.19–11.09)	0.72
Hyperlipidemia using statins	0.23 (0.07-0.79)	0.02	0.23 (0.05–0.96)	0.04
Serous papillary
No hyperlipidemia	1		1
Hyperlipidemia not using statins	0.78 (0.43–1.39)	0.40	0.52 (0.26–1.03)	0.06
Hyperlipidemia using statins	1.06 (0.69–1.64)	0.78	1.01 (0.62–1.64)	0.98

Data are hazard ratio (95% confidence interval).

Adjusted for age at diagnosis, race, BMI, ASA class (PFS only), metformin use, residual tumor >1 cm, primary cytoreductive surgery, FIGO stage, tumor site and grade.